67 documents found, page 1 of 7

Executive functioning training in typically developing adolescents: data review...

Music therapy assessment with the IMCAP-ND: a pilot study

Background: Music therapy (MT) appears to be a valuable complementary intervention for children diagnosed with neurodevelopmental conditions, namely, autism spectrum disorders (ASD), who often present cognitive, academic, communicative, and social difficulties. Music therapy has been increasingly recommended as a standard support service for communication and social interaction in this specific neuropediatric s...

Looking for the brain inside the initial teacher training and outreach books in...

The fascination with brain research is widespread, and school teachers are no exception. This growing interest, usually noticed by the increased supply of short-term training or books on how to turn the brain more efficient, leads us to think about their basic training and outreach resources available. Little is known about what the official Initial Teacher Training (ITT) offers concerning the brain literature ...

At-distance neurocognitive rehabilitation during COVID-19 pandemic: A first gla...

Despite the use of digital communication technologies in neurocognitive rehabilitation has been widely used in face-to-face interventions, the difficulties of using ICT-based tools to provide rehabilitation services and the unfamiliarity of the neuropsychologists with internet interventions limited the use of these kinds of interventions in their clinical practices. The lockdown and mitigating measures associat...

A avaliação multidomínio da eficácia de programas de reabilitação neurocognitiv...

O envolvimento das novas tecnologias digitais nos processos de estimulação e reabilitação neurocognitiva (RNC) tem potenciado a eficácia e eficiência dos serviços de RNC, nomeadamente através de uma maior personalização aos perfis funcionais de cada indivíduo. Apesar disso, os protocolos de avaliação da eficácia destes processos baseiam-se maioritariamente em resultados de instrumentos tradicionais que não forn...

Disentangling pantomime from early sign in a new sign language: window into lan...

In this study, we aim to disentangle pantomime from early signs in a newly-born sign language: Sao Tome and Principe Sign Language. Our results show that within 2 years of their first contact with one another, a community of 100 participants interacting everyday was able to build a shared language. The growth of linguistic systematicity, which included a decrease in use of pantomime, reduction of the amplitude ...

Resiliência em adolescentes com Diabetes Mellitus Tipo 1

Neste estudo apresentam-se os resultados obtidos por adolescentes com DM 1 na escala de resiliência (HKRAM) e a sua relação com as variáveis sociodemográficas e sociofamiliares. Concluiu-se que a maioria dos participantes no estudo apresenta valores médios de resiliência bons, contudo alguns adolescentes obtiveram valores muito baixos. O que significa que a HKRAM permite identificar adolescentes com áreas probl...

Acontecimentos vitais stressantes em adolescentes com Diabetes Mellitus tipo 1

Neste trabalho, são apresentados os acontecimentos vitais stressantes e o impacto emocional por eles causado, num grupo de adolescentes com DM 1. Estuda-se a sua relação com as caraterísticas sociodemográficas e sociofamiliares. Conclui-se que são os adolescentes com retenção escolar identificam mais AVS e com maior impacto emocional.

Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal

Introdução: A monitorização da segurança associada aos medicamentos biológicos e biossimilares exige um sistema de informação alinhado com o enquadramento regulamentar. Tendo em conta que podem ocorrer descontinuidades entre a regulamentação europeia, nacional e a respetiva tradução operacional, importa pesquisar e identificar essas lacunas. Material e Métodos: Foi desenvolvida uma análise qualitativa dos supor...

Biologicals and biosimilars: safety issues in Europe

ABSTRACT Introduction: Medicinal products of a biological origin are approved by the EMA at a centralized level. However, there is no harmonization about their use in Europe. The current regulation referring to the safety of biological medicinal products and biosimilars in Europe has been identified. The safety associated with medicinal products of a biological origin is assured by the pharmacovigilance system,...